Quarterly results - GSK
Discover our latest financial performance announcement and search for historical quarterly results materials. Visit our corporate reporting archive for our Annual Reports. Filter by year.
Investors | GSK
From quarterly updates to key announcements, here you can access GSK investor-related information.
Contact us - GSK
How can we help you? Visit our for patients, caregivers and HCPs in US. Alternatively, call us on Tel: +1 888 825 5249. Monday, Tuesday, Thursday, Friday: 08:30 AM - 5:30 PM ET. Wednesday: 8:30 AM - 4:00 PM ET. Closed holidays. GSK Asia House. 23 Rochester Park. 139234.
United Kingdom - GSK
United Kingdom. At GSK, we unite science, technology and talent to get ahead of disease together. We prevent and treat disease with vaccines, specialty and general medicines investing in four core therapeutic areas: infectious diseases, HIV, respiratory/immunology, and oncology.
Update - GSK Consumer Healthcare | GSK US
Jan 15, 2022 · GlaxoSmithKline (GSK) plc today confirms that it has received three unsolicited, conditional and non-binding proposals from Unilever plc to acquire the GSK Consumer Healthcare business. The latest proposal received on 20th December 2021 was for a total acquisition value of £50 billion comprising £41.7 billion in cash and £8.3 billion in ...
Home | GSK
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.
Home | GSK US
October 24 2024 GSK invests up to $800 million in Pennsylvania site, largest manufacturing investment in U.S. October 24 2024 New data for AREXVY, GSK’s respiratory syncytial virus vaccine, show potential to help protect a broader group of adults at …
Update - GSK Consumer Healthcare
Jan 15, 2022 · GlaxoSmithKline (GSK) plc today confirms that it has received three unsolicited, conditional and non-binding proposals from Unilever plc to acquire the GSK Consumer Healthcare business. The latest proposal received on 20th December 2021 was for a total acquisition value of £50 billion comprising £41.7 billion in cash and £8.3 billion in ...
Locations - GSK
Locations. Learn more about GSK around the world by visiting our market websites listed out below. For contact information including product information websites for healthcare professionals, visit our Worldwide directory. Our market company websites and web pages are intended for non-UK audiences.
Completion of the demerger of Haleon and share consolidation of …
Jul 18, 2022 · GSK plc (LSE/NYSE: GSK) has today (Monday 18 July 2022) completed the demerger of the Consumer Healthcare business from the GSK Group to form the Haleon Group.